Physician profile
Milton E Coll
NPI 1487657086
$2,677.62
in general payments reported to CMS, 2019-2025
22 companies · $301 in 2025
The $301 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $480 · 2020: $78.01 · 2021: $190 · 2022: $272 · 2023: $690 · 2024: $666 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,657.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,657.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Ih Ab | $726.38 | 2023-2025 | Lofric, Lofric |
| Astellas Pharma US INC | $455.55 | 2019-2024 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $325.58 | 2023-2024 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $208.23 | 2019-2024 | Erleada |
| Medtronic, INC. | $146.77 | 2021-2024 | Interstim |
| 180 Medical, INC. | $125.27 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $97.26 | 2019-2024 | Adstiladrin |
| Teleflex LLC | $84.42 | 2023 | Urolift |
| Urogen Pharma, INC. | $82.36 | 2023-2024 | Jelmyto |
| Dentsply Ih INC. | $66.32 | 2022 | |
| Dendreon Pharmaceuticals LLC | $55.66 | 2019 | |
| Abbvie INC. | $48.28 | 2019-2024 | |
| Urovant Sciences INC | $47.99 | 2022 | |
| Pfizer INC. | $30.57 | 2019 | |
| Progenics Pharmaceuticals, INC. | $28.71 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Photocure INC | $28.55 | 2019 | |
| Axonics, INC. | $25.53 | 2021 | |
| Tolmar, INC. | $23.25 | 2023 | |
| Tolmar Pharmaceuticals, INC. | $21.42 | 2019 | |
| Genzyme Corporation | $19.34 | 2022 | |
| Endo Pharmaceuticals INC. | $15.10 | 2019 | |
| Mission Pharmacal Company | $15.08 | 2024 | Uribel Tabs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Milton Coll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.